Myocardial lipid content in Fabry disease: a combined 1H-MR spectroscopy and MR imaging study at 3 Tesla.

about

Myocardial lipid content in Fabry disease: a combined 1H-MR spectroscopy and MR imaging study at 3 Tesla.

Item

http://www.wikidata.org/entity/Q36177437

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Myocardial lipid content in Fa ...... d MR imaging study at 3 Tesla.

@ast

Myocardial lipid content in Fa ...... d MR imaging study at 3 Tesla.

@en

type

Item

label

Myocardial lipid content in Fa ...... d MR imaging study at 3 Tesla.

@ast

Myocardial lipid content in Fa ...... d MR imaging study at 3 Tesla.

@en

prefLabel

Myocardial lipid content in Fa ...... d MR imaging study at 3 Tesla.

@ast

Myocardial lipid content in Fa ...... d MR imaging study at 3 Tesla.

@en

P1476

Myocardial lipid content in Fa ...... nd MR imaging study at 3 Tesla

@en

P2093

A S Kunz

http://www.w3.org/2001/XMLSchema#string

C Wanner

http://www.w3.org/2001/XMLSchema#string

F Weidemann

http://www.w3.org/2001/XMLSchema#string

M Beer

http://www.w3.org/2001/XMLSchema#string

M Horn

http://www.w3.org/2001/XMLSchema#string

T A Bley

http://www.w3.org/2001/XMLSchema#string

T Gassenmaier

http://www.w3.org/2001/XMLSchema#string

P2860

Gender-specific normal levels of myocardial metabolites determined by localized 1H-magnetic resonance spectroscopy.

MR of multi-organ involvement in the metabolic syndrome.

Metabolic imaging of myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers.

Effect of Gd-DTPA-BMA on choline signals of HT29 tumors detected by in vivo 1H MRS.

Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus.

Rapid quantification of myocardial lipid content in humans using single breath-hold 1H MRS at 3 Tesla.

Non-invasive determination of myocardial lipid content in Fabry disease by 1H-MR spectroscopy.

Prevalence of lysosomal storage disorders.

Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease.

Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy.

P2888

s12872-016-0382-4

P304

205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12872-016-0382-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Herbert Köstler

Andreas Max Weng

B Petritsch

P577

2016-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1030747981

http://www.w3.org/2001/XMLSchema#string

P698

27793097

http://www.w3.org/2001/XMLSchema#string

P932

5084400

http://www.w3.org/2001/XMLSchema#string